Academic Journal

Interleukin-6 in Rheumatoid Arthritis

التفاصيل البيبلوغرافية
العنوان: Interleukin-6 in Rheumatoid Arthritis
المؤلفون: Pandolfi, Franco, Franza, Laura, Andriollo, Gloria, Nucera, Eleonora
المساهمون: Pandolfi, Franco, Franza, Laura, Carusi, Valentina, Altamura, Simona, Andriollo, Gloria, Nucera, Eleonora
بيانات النشر: MDPI
سنة النشر: 2020
المجموعة: Università Cattolica del Sacro Cuore: PubliCatt
مصطلحات موضوعية: IL-6, inflammation, rheumatoid arthritis, Antibodies, Monoclonal, Arthritis, Rheumatoid, Disease Progression, Humans, Interleukin-6, Molecular Targeted Therapy, Signal Transduction, Settore MED/09 - MEDICINA INTERNA
الوصف: The role of interleukin (IL)-6 in health and disease has been under a lot of scrutiny in recent years, particularly during the recent COVID-19 pandemic. The inflammatory pathways in which IL-6 is involved are also partly responsible of the development and progression of rheumatoid arthritis (RA), opening interesting perspectives in terms of therapy. Anti-IL-6 drugs are being used with variable degrees of success in other diseases and are being tested in RA. Results have been encouraging, particularly when anti-IL-6 has been used with other drugs, such as metothrexate (MTX). In this review we discuss the main immunologic aspects that make anti-IL-6 a good candidate in RA, but despite the main therapeutic options available to target IL-6, no gold standard treatment has been established so far.
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/32718086; info:eu-repo/semantics/altIdentifier/wos/WOS:000567289500001; volume:21; issue:15; firstpage:5238; lastpage:N/A; issueyear:2020; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/10807/161301
DOI: 10.3390/ijms21155238
الاتاحة: http://hdl.handle.net/10807/161301
https://doi.org/10.3390/ijms21155238
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.FFB305CE
قاعدة البيانات: BASE